-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613.P1.63 613. Acute Myeloid Leukemia: Clinical Studies: Poster I

Acute Myeloid Leukemia: Clinical Studies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A, Level 2 (Orange County Convention Center)

Courtney DiNardo, MD1, Stéphane de Botton2*, Daniel A Pollyea3*, Eytan M Stein, M.D.4, Amir T. Fathi, MD5, Gail J Roboz, MD6, Robert Collins, MD7, Ronan T. Swords, MD, PhD, FRCPI, FRCPath8, Ian W. Flinn, MD, PhD9, Jessica K Altman10*, Martin S Tallman, MD11, Hagop M. Kantarjian, MD12, Adnan Derti13*, Meredith Goldwasser13*, Malia Prahl13*, Bin Wu13*, Katharine Yen13*, Sam Agresta13 and Richard M. Stone, MD14

1University of Texas MD Anderson Cancer Center, Houston, TX
2Institut Gustave Roussy, Villejuif, France
3University of Colorado Cancer Center, Aurora, CO
4Memorial Sloan Kettering Cancer Center, New York, NY
5Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
6Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York, NY
7University of Texas Southwestern Medical Center, Dallas, TX
8Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Hospitals, Miami, FL
9Hematologic Malignancies Research Program, Sarah Cannon Research Institute, Nashville, TN
10Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
11Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
12Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
13Agios Pharmaceuticals, Cambridge, MA
14Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Etienne Paubelle1*, Alice Marceau2*, Florence Zylbersztejn3*, Mickael Dussiot4*, Ivan Cruz Moura, PhD5, Pascale Cornillet-Lefebvre, MD6*, Jacques Delaunay, MD7*, Alan K. Burnett8, Sylvie Castaigne9, Philippe Guardiola, MD10, Norbert Ifrah, MD, PhD11, Hervé Dombret12, Claude Preudhomme2, Robert K Hills, DPhil13 and Olivier Hermine14,15*

1Hôpital Necker - APHP, Paris Descartes – Sorbonne Paris Cité University, paris, France
2Hematology Laboratory, CHRU Lille, Lille, France
3Imagine Institute- Inserm UMR 1163, Paris Descartes – Sorbonne Paris Cité University, paris, France
4UMR 1163, Institut Imagine, Paris, France
5Department of Hematology, Imagine Institute, Hôpital Universitaire Necker -Enfants Malades Paris, Paris, France
6CHU Reims, reims, France
7Department of Hematology, Nantes University Hospital, Nantes, France
8Haematology, Haematology, NCRI Working Group, United Kingdom, Cardiff, United Kingdom
9Dept. Hematologie, Hopital Mignot, Le Chesnay, France
10Service des Maladies du Sang, CHU Angers, Angers, France
11Hematology Department, University Hospital, Angers, France
12Hematology, Hôpital Saint-Louis, Paris, France
13Department of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom
14LABEX GR-Ex, Paris, France
15Hematology, Hôpital Necker Enfants Malades, Paris, France

Selina Luger, MD1, Victoria X Wang2*, Elisabeth Paietta, PhD3, Rhett P. Ketterling, MD4*, Witold Rybka, MD5, Hillard M. Lazarus, MD6, Mark R Litzow, MD7, Jacob M. Rowe, MD8, Richard A. Larson, MD9, Frederick R Appelbaum, MD10 and Martin S. Tallman, MD11,12

1Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
2ECOG-ACRIN Biostatistics Center, Dana Farber Cancer Institute, Boston, MA
3Cancer Center, Montefiore Medical Center North Division, Bronx, NY
4Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
5Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA
6Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH
7Division of Hematology, Mayo Clinic, Rochester, MN
8Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
9University of Chicago, Chicago, IL
10Fred Hutchinson Cancer Research Center & University of Washington, Seattle, WA
11Memorial Sloan-Kettering Cancer Center, New York, NY
12Northwestern University Feinberg School of Medicine, Chicago, IL

Theresa Kretschmann1*, Christoph Röllig, MD2*, Brigitte Mohr1*, Michael Kramer, MSc.3*, Matthias Stelljes4, Martin Kaufmann, MD5, Kerstin Schäfer-Eckart6*, Claudia D. Baldus, MD, PhD7*, Alwin Krämer8*, Hermann Einsele9, Mathias Hänel10*, Regina Herbst, MD11*, Stefan W. Krause, MD12*, Andreas Neubauer, MD13, Kristina Sohlbach14*, Martin Bornhäuser, MD2*, Christian Thiede, MD15, Wolfgang E. Berdel, MD16, Hubert Serve, MD17*, Johannes Schetelig, MD, M.Sc18,19, Gerhard Ehninger, MD3 and Friedrich Stölzel, MD15,20*

1Universitätsklinikum TU Dresden, Dresden, Germany
2Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
3Medical Dept. 1, University Hospital TU Dresden, Dresden, Germany
4Department of Medicine A/Hematology and Oncology, University of Münster, Münster, Germany
5Robert Bosch Krankenhaus, Stuttgart, Germany
6Klinikum Nord, Nürnberg, Germany
7Charité University Hospital, Berlin, Germany
8Universitätsklinikum Heidelberg, Heidelberg, Germany
92Department of Internal Medicine. II, Wuerzburg, Germany
10Klinik für Innere Medizin III, Klinikum, Chemnitz, Germany
11Klinikum Chemnitz, Chemnitz, Germany
12Medizinische Klinik 5, Hämatologie und Internistische Onkologie, Universitätsklinikum Erlangen, Erlangen, Germany
13Dept. Hematology, Oncology, Immunology, Philipps University of Marburg, Medical Center of the University Giessen and Marburg, Marburg, Germany
14Philipps University of Marburg, Medical Center of the University Giessen and Marburg, Marburg, Germany
15Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany
16Universitätsklinikum Münster, Münster, Germany
17Dept. of Internal Medicine, University Hospital of Frankfurt, Frankfurt, Germany
18Medizinische Klinik I, Universitaetsklinikum C.G.Carus, Dresden, Germany
19DKMS German Bone Marrow Donor Center, Dresden, Germany
20Study Alliance Leukemia SAL, Dresden, Germany

Bin Fan, PhD*, Kha Le, PhD*, Erika Manyak, BASc*, Hua Liu*, Malia Prahl*, Chris J Bowden*, Scott Biller*, Sam Agresta, MD and Hua Yang, PhD*

Agios Pharmaceuticals, Cambridge, MA

Hideki Muramatsu, MD, PhD1, Tomoyuki Watanabe2*, Daisuke Hasegawa, MD, PhD3*, Park Myoung-ja4*, Shotaro Iwamoto5*, Takashi Taga, MD, PhD6*, Etsuro Ito, MD, PhD7, Tsutomu Toki, PhD7, Kiminori Terui7, Ryu Yanagisawa8*, Katsuyoshi Koh, MD, PhD9*, Akiko M. Saito10*, Keizo Horibe, MD, PhD10, Yasuhide Hayashi, MD, PhD4, Souichi Adachi, MD, PhD11, Shuki Mizutani, MD, PhD12* and Kenichiro Watanabe13*

1Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
2Department of Nutritional Science, Faculty of Psychological and Physical Science, Aichi Gakuin University, Nisshin, Japan
3Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan
4Department of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan
5Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan
6Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
7Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
8Department of Hematology and Oncology, Nagano Children's Hospital, Azumino, Japan
9Department of Hematology and Oncology, Saitama Children's Medical Center, Saitama, Japan
10Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
11Department of Human Health Sciences, Kyoto University, Kyoto, Japan
12Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Bunkyo-ku, Japan
13Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan

Aditya Deshpande1*, Maria Monica Gramatges, MD, PhD2, Ghadir S. Sasa, MD2*, Philip J Lupo, PhD, MPH3*, Rachel E Rau, MD2, Michele S. Redell, MD, PhD2, Terzah M. Horton, MD, PhD2, Michael E Scheurer, PhD, MPH3* and Karen R. Rabin, MD, PhD2

1University of Texas School of Public Health, Houston, TX
2Pediatrics, Hematology/Oncology, Baylor College of Medicine, Houston, TX
3Department of Pediatrics , Hematology-Oncology Section, Baylor College of Medicine, Houston, TX

Birendra KC, MD*, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Naval Daver, MD, Gautam Borthakur, MD, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD, Dai Chihara, MD, PhD, Tapan Kadia, MD, Prithviraj Bose, MD*, Zeev Estrov, MD, Naveen Pemmaraju, MD, Farhad Ravandi, MD and Jorge E. Cortes, MD

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Taeha Kim, MD1*, Joseph Shatzel, MD2*, Harley Friedman, MD3* and Frederick Lansigan, MD4

1Dartmouth Hitchcock Medical Center, Lebanon, NH
2Department of Hematology/Oncology, Oregon Health and Science University, Portland, OR
3Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH
4Hematology, Dartmouth-Hitchcock Medical Center, Lebanon, NH

Chezi Ganzel1*, Larry D. Cripe, MD2, Zhouxin Sun3*, Hugo F. Fernandez, M.D.4, Peter A Cassileth, MD5, Dan Douer, MD6, Jacob M. Rowe, MD1,7, Elisabeth Paietta, PhD8, Michael O'Connell9*, Peter H Wiernik10*, John M. Bennett, MD11, Mark R Litzow, MD12, Selina Luger, MD13, Hillard M. Lazarus, MD14 and Martin S. Tallman, MD15

1Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
2Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN
3Dana Farber Cancer Institute, Tampa, FL
4Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL
5Deceased prior to publication, University of Miami, Miami, FL
6Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
8Cancer Center, The North Division of Montefiore Medical Center, Bronx, NY
9Mayo Clinic, Rochester, MN
10Beth Israel Medical Center, New York
11University of Rochester, Rochester, NY
12Division of Hematology, Mayo Clinic, Rochester, MN
13Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
14Medicine - Hematology and Oncology, University Hospitals Case Medical Center, Cleveland, OH
15Memorial Sloan Kettering Cancer Center, New York

Taiki Ando, MD1*, Etsuko Yamazaki, MD2,3, Haruka Teshigawara, MD4*, Fujii Eriko, MD5*, Yoshimi Ishii, MD1*, Wataru Yamamoto, MD1*, Kenji Motohashi, MD1*, Takayoshi Tachibana, MD2*, Maki Hagihara, MD2*, Kenji Matsumoto, MD1*, Masatsugu Tanaka5*, Hashimoto Chizuko, MD6*, Koharazawa Hideyuki, MD4*, Fujimaki Katsumichi, MD7*, Jun Taguchi, MD4*, Naoto Tomita, MD2, Hiroyuki Fujita, MD8, Heiwa Kanamori5 and Shin Fujisawa, MD1*

1Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
2Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
3Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan, Yokohama, Japan
4Department of Hematology, Shizuoka Red Cross Hospital, Shizuoka, Japan
5Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
6Hematology/Oncology, Yamato Municipal Hospital, Yamato, Japan
7Hematology/Immunology, Fujisawa City Hospital, Fujisawa, Japan
8Department of Hematology, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan

Bailleux Caroline1*, Fieux Thomas2*, Doyen Jerome3*, Gastaud Lauris4*, Gallamini Andrea4*, Kaphan Regis5*, Re Daniel4*, Gutnecht Jean6*, Garnier Georges7*, Rossignol Benoit8*, Thyss Antoine2*, Franck E. Nicolini9 and Frederic Peyrade, MD10*

1Hematology, Antoine Lacassagne Center, NICE, France
2Oncology hematology, Antoine Lacassagne Center, Nice, France
3Radiation oncology, Antoine Lacassagne Center, NICE, France
4Oncology hematology, Antoine Lacassagne Center, NICE, France
5Internal Medicine, Cannes General Hospital, Cannes, France
6Oncology, Frejus Saint Raphael Hospital, Frejus, France
7Hematology and Oncology, Princess Grace Hospital, Monaco, France
8Oncology and hematology, Draguignan Hospital, Draguignan, France
9Hématologie, Centre Hospitalier Lyon Sud, Pierre Benite, & INSERM, Lyon, France
10Department of Hematology, Centre Antoine Lacassagne, Nice, France

Kaixun Hu, MD1*, Yajing Huang, MD1*, Huisheng Ai, MD2*, Mei Guo1*, Yu Changlin1*, Qiao Jianhui1*, Qiyun Sun1*, Zheng Dong1*, Hongli Zuo1*, Bo CAI3* and Xuliang Shen, MD4*

1Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, beijing, China
2Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, BEIJING, China
3Affiliated Hospital of Academy of Military Medical Sciences, BEIJING, China
4Heping Hospital of Changzhi Medical College, Changzhi, China

Ahmad Zarzour, MD1, Aziz Nazha, MD2, Matt Kalaycio, MD3, Bhumika J. Patel4*, Aaron T. Gerds, MD, MS1, Michael J. Clemente5*, Cassandra M Hirsch6*, Jennifer S. Carew, PhD4, Anjali S. Advani, MD1, Srinivasa R. Sanikommu, MBBS7, Bartlomiej Przychodzen, MSc4*, Hetty E. Carraway, MD, MBA1, Sudipto Mukherjee, MD, PhD1, Jaroslaw P. Maciejewski, MD, Ph.D.4 and Mikkael A. Sekeres, MD, MS1

1Leukemia Program, Cleveland Clinic, Cleveland, OH
2Leukemia Program, Department of Hematology and Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
3Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
4Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
5Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH
6Department of Translational Hematology and Oncology Research, Taussing Cancer Institute, Cleveland Clinic, Cleveland, OH
7Cleveland Clinic Taussing Cancer Institute, Cleveland, OH

Tomoki Naoe, MD, Ph.D.1, Toru Sakura, MD, PhD2*, Yukio Kobayashi, MD, PhD3, Kensuke Usuki, MD, Ph.D.4*, Toshihiro Miyamoto, MD, PhD5, Hiroatsu Iida, MD, PhD1*, Satoshi Morita, PhD6*, Erkut Bahceci, MD7, Masahito Kaneko, RPh8*, Shunsuke Yamada, M.Eng8*, Shigeru Takeshita, MSc8* and Shuichi Miyawaki, MD, Ph.D.9

1National Hospital Organization Nagoya Medical Center, Nagoya, Japan
2Saiseikai Maebashi Hospital, Gunma, Japan
3National Cancer Center Hospital, Tokyo, Japan
4Deptartment of Hematology, NTT Medical Center Tokyo, Tokyo, Japan
5Kyushu University Hospital, Fukuoka, Japan
6Kyoto University Hospital, Kyoto, Japan
7Astellas Pharma US, Inc., Northbrook, IL
8Astellas Pharma, Inc., Tokyo, Japan
9Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan

Elzbieta Patkowska, MD1,2*, Joanna Gora Tybor, MD PhD1*, Ewa Lech Maranda, MD PhD1,2*, Maciej Kazmierczak, MD PhD3*, Marta Baranska, MD, PhD3*, Andrzej Szczepaniak, MD3*, Monika Paluszewska, MD, PhD4*, Wieslaw W Jedrzejczak, MD PhD4*, Renata Guzicka Kazmierczak, MD, PhD5*, Wanda Knopinska Posluszny, MD, PhD6*, Olga Grzybowska Izydorczyk, MD, PhD7*, Jaroslaw Piszcz, MD, PhD8, Izabela Deren Wagemann, MD, PhD9* and Krzysztof Warzocha, MD, PhD1*

1Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
2Department of Hematology and Transfusion Medicine, Centre of Postgraduate Medical Education, Warsaw, Poland
3Department of Hematology and Bone Marrow Transplantation, University of Medical Sciences, Poznan, Poland
4Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland
5Department of Hematology, Pomeranian Medical University, Szczecin, Poland
6Department of Hematology, Hospital of the Ministry of Interior, Warmia and Mazury University, Olsztyn, Poland
7Department of Hematology, Medical University of Lodz, Lodz, Poland
8Hematology Department, Medical University of Bialystok, Bialystok, Poland
9Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland

Hind Bennani, PharmD1*, Véronique Saada, PharmD2*, Christophe Willekens, MD3* and Jacques Vargaftig, MD4*

1Laboratoire de Biologie, Hôpital René Huguenin - Institut Curie, Saint-Cloud, France
2Département de biologie-pathologie, Institut Gustave Roussy, Villejuif, France
3Service d’Hématologie, Gustave Roussy Cancer Center, Villejuif, France
4Service d’Hématologie, Hôpital René Huguenin - Institut Curie, Saint-Cloud, France

Renata Abrahão, MD, MSc1,2*, Ruth H Keogh, DPhil3*, Daphne Y Lichtensztajn, MD, MPH2*, Rafael Marcos-Gragera, MD, PhD4*, Bruno C. Medeiros, MD5, MIchel P Coleman, FFPH1*, Raul C. Ribeiro, MD6 and Theresa HM Keegan, PhD, MSc2,7*

1Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, England
2Cancer Prevention Institute of California, Fremont, CA
3Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, England
4Epidemiology Unity and Cancer Registry of Girona, Institute for Biomedical Research de Girona, Girona, Spain
5Department of Medicine, Division of Hematology, Stanford University, Stanford, CA
6St. Jude Children's Research Hospital, Memphis, TN
7Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA

*signifies non-member of ASH